Author | Brian T. Hill, MD, PhD | OncLive

Author | Brian T. Hill, MD, PhD

Articles

Dr. Hill on the Safety Profile of Selinexor in Relapsed/Refractory DLBCL

June 24, 2020

Video

Brian T. Hill, MD, PhD, discusses the safety profile of selinexor in relapsed/refractory diffuse large B-cell lymphoma.

Dr. Hill on the FDA Approval of Selinexor in DLBCL

June 22, 2020

Video

Brian T. Hill, MD, PhD, discusses the FDA approval of selinexor (Xpovio) in diffuse large B-cell lymphoma (DLBCL).

Dr. Hill on Resistance to BTK Inhibition in CLL

January 16, 2019

Video

Brian T. Hill, MD, PhD, assistant professor, Hematology and Oncology, Cleveland Clinic, discusses resistance to BTK inhibition in chronic lymphocytic leukemia (CLL).

Dr. Hill Discusses the Progression of CLL Treatment

November 08, 2018

Video

Brian T. Hill, MD, PhD, assistant professor, Hematology and Oncology, Cleveland Clinic, discusses the progression of treatment of patients with chronic lymphocytic leukemia.

x